News & Perspective

Jul 02, 2015

Jul 02, 2015
Vaccine vials

GSK upgrade delays supply of adjuvanted H5N1 vaccine

A recommendation for occupational use was tabled until the vaccine becomes available.

Jul 01, 2015

Jul 01, 2015

News Scan for Jul 01, 2015

National Ebola center
H pylori vaccine tests well
Pandemrix-narcolepsy study

Mar 10, 2015

Mar 10, 2015

Flu Scan for Mar 10, 2015

More queries on flu vaccine mismatch
Global flu activity

Oct 27, 2014

Oct 27, 2014

CSL-Novartis deal includes US cell-based flu vaccine plant

The $275 million deal will make the company the second leading player in the $4 billion global flu vaccine market.

Jun 17, 2014

Jun 17, 2014

Flu Scan for Jun 17, 2014

H7N9 in China
Low global flu activity
Recombinant flu vaccine contract

Jun 16, 2014

Jun 16, 2014
Novartis Holly Springs

FDA OKs Novartis's US cell-based flu vaccine facility

The agency has approved a plant in Holly Springs, N.C.

May 02, 2014

May 02, 2014

News Scan for May 02, 2014

More MERS-CoV antibodies
Ebola in Guinea
Renamed biodefense board
Universal flu vaccine

Oct 23, 2013

Oct 23, 2013

Flu Scan for Oct 23, 2013

New H7N9 case in China
Flu vaccine capacity building

Oct 02, 2013

Oct 02, 2013
flu vaccine vial

HHS: Fill-and-finish contracts will boost flu vaccine capacity

New federal contracts establish a "fill and finish" network for flu vaccine to boost capacity by 20%.

May 10, 2013

May 10, 2013

Experts offer dim view of potential vaccine response to H7N9

If the H7N9 influenza virus now circulating in China evolves into a pandemic strain, the world is likely to have great difficulty providing adequate supplies of an effective vaccine in time to blunt its impact, according to a viewpoint article by three experts in the Journal of the American Medical Association (JAMA).

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»